Perspective
Published in:
Volume 1 / Year 2012 / Issue 3-4
Volume 1 / Year 2012 / Issue 3-4
Health professionals in the risk communication process on counterfeit medicines
Author(s): Luc Besançon
Page: 135-7
Page: 135-7
Abstract: Communication is a key component in the fight against counterfeit medicines affecting the lives of patients. Two types of risk communication should be distinguished: pro-active and reactive. Reactive communication… Read More »
Terminology for biosimilars–a confusing minefield
Author byline as per print journal: Robin Thorpe, PhD, FRCPath; Meenu Wadhwa, PhD Abstract: Biosimilars are firmly established in the EU as copy biologicals with a clear and effective regulatory route for… Read More »